Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details)

v3.23.2
Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests $ (34,525) $ (32,574) $ (68,133) $ (66,292) $ (127,338)
Non-controlling interests in consolidated entities (34,452)   (34,452)   8,304
Urica          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     (1,301)   (1,251)
Non-controlling interests in consolidated entities $ (4,806)   $ (4,806)   $ (3,908)
Non-controlling ownership 34.50%   34.50%   34.50%
Aevitas          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests         $ (425)
Non-controlling interests in consolidated entities         $ (5,753)
Non-controlling ownership         45.90%
Avenue          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (9,860)   $ (2,355)
Non-controlling interests in consolidated entities $ (4,981)   $ (4,981)   $ 3,054
Non-controlling ownership 89.40%   89.40%   82.00%
Baergic          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests         $ (113)
Non-controlling ownership         39.00%
Cellvation          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (47)   $ (102)
Non-controlling interests in consolidated entities $ (1,926)   $ (1,926)   $ (1,791)
Non-controlling ownership 21.30%   21.30%   21.70%
Checkpoint          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (21,978)   $ (48,406)
Non-controlling interests in consolidated entities $ (20,204)   $ (20,204)   $ (16,008)
Non-controlling ownership 86.80%   86.80%   81.50%
Coronado SO          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ 0   $ 0
Non-controlling interests in consolidated entities $ (290)   $ (290)   $ (291)
Non-controlling ownership 13.00%   13.00%   13.00%
Cyprium          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (741)   $ (1,173)
Non-controlling interests in consolidated entities $ (4,742)   $ (4,742)   $ (3,817)
Non-controlling ownership 28.30%   28.30%   29.80%
Helocyte          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ 33   $ (122)
Non-controlling interests in consolidated entities $ (5,911)   $ (5,911)   $ (5,900)
Non-controlling ownership 17.50%   17.50%   18.30%
JMC          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (8,104)   $ (12,458)
Non-controlling interests in consolidated entities $ 19   $ 19   $ 7,429
Non-controlling ownership 45.10%   45.10%   41.60%
Mustang          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (26,127)   $ (60,821)
Non-controlling interests in consolidated entities $ 10,848   $ 10,848   $ 37,640
Non-controlling ownership 79.10%   79.10%   82.70%
Oncogenuity          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ (8)   $ (111)
Non-controlling interests in consolidated entities $ (1,665)   $ (1,665)   $ (1,575)
Non-controlling ownership 27.00%   27.00%   24.90%
Tamid          
Noncontrolling Interest [Line Items]          
Net loss attributable to non-controlling interests     $ 0   $ (1)
Non-controlling interests in consolidated entities $ (794)   $ (794)   $ (776)
Non-controlling ownership 22.80%   22.80%   22.80%